HR3537-117 · 117th Congress
Signed into Law
Signed Dec 23, 2021Accelerating Access to Critical Therapies for ALS Act
Accelerating Access to Critical Therapies for ALS Act This bill establishes grant programs to address neurodegenerative diseases, such as amyotrophic lateral sclerosis (also known as ALS or Lou Gehrig's disease), and contains other related provisions. The Department of Health and Human Services (HHS) shall award grants to eligible entities to facilitate patients' access to investigational drugs that diagnose or treat ALS. The Food and Drug Administration (FDA) shall award grants to public and pr…
VOTE BREAKDOWN
Final passage · 292 politicians tracked
287
YEA
3
NAY
0
PRESENT
2
NOT VOTING
98% YEA1% NAY
BY PARTY
DEMOCRAT144 YEA · 0 NAY
99%
REPUBLICAN143 YEA · 3 NAY
97%
MONEY ON THIS BILL
Top donor industries among YEA voters vs NAY voters · lobbying activity in affected industries
⬆ YEA voters — top donor industries
- 1. Party & Leadership4186 pts
- 2. Labor Unions2785 pts
- 3. Single-Issue Advocacy2645 pts
⬇ NAY voters — top donor industries
- 1. Single-Issue Advocacy33 pts
- 2. Party & Leadership30 pts
- 3. Real Estate15 pts
◎ Lobbying activity by issue area
No bill-issue lobbying matches.
“Pts” = sum of per-member industry donation scores (% of total donations from that industry, summed across the group). Higher means that industry funds a larger share of contributions for that voting bloc.
INDIVIDUAL VOTES
Recorded positions for tracked politicians
SPONSORS
Mike Quigley
D-IL · Primary
166 COSPONSORS
BIPARTISAN